MARKET

AMED

AMED

Amedisys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

224.06
-9.61
-4.11%
After Hours: 224.06 0 0.00% 16:26 09/23 EDT
OPEN
232.10
PREV CLOSE
233.67
HIGH
233.14
LOW
223.62
VOLUME
202.86K
TURNOVER
--
52 WEEK HIGH
248.96
52 WEEK LOW
121.00
MARKET CAP
7.27B
P/E (TTM)
57.93
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Hedge Funds Are Piling Into Amedisys Inc (AMED)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress
Insider Monkey · 09/17 01:28
Imagine Holding Amedisys (NASDAQ:AMED) Shares While The Price Zoomed 466% Higher
Buying shares in the best businesses can build meaningful wealth for you and your family. While the best companies are...
Simply Wall St. · 09/12 14:53
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Podcasts, Stitcher and Spotify (click the highlighted links). The tech sector will be in focus again in the week ahead as investors gauge if short-term pandemic plays like Zscaler (ZS) Palo Alto Networks (PANW), Fortinet (FTNT), Zoom Video (ZM) and DocuSign (DOCU) are good for the longer haul
Seekingalpha · 09/05 12:21
Amedisys to Present at the Baird 2020 Global Healthcare Conference
GlobeNewswire · 08/31 21:30
Why Is Amedisys (AMED) Up 6.4% Since Last Earnings Report?
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 08/27 16:31
Amedisys Banks on Coronavirus-Driven Growth Amid Cost Woes
Zacks · 08/17 15:45
Stocks Showing Rising Market Leadership: Addus Homecare Earns 82 RS Rating
On Tuesday, Addus Homecare earned a positive adjustment to its Relative Strength (RS) Rating, from 76 to 82. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
Investor's Business Daily · 08/04 21:58
Were Hedge Funds Right About Souring On Amedisys Inc (AMED)?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of
Insider Monkey · 08/03 16:14
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMED. Analyze the recent business situations of Amedisys through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMED stock price target is 256.00 with a high estimate of 290.00 and a low estimate of 214.00.
EPS
Institutional Holdings
Institutions: 491
Institutional Holdings: 32.49M
% Owned: 100.08%
Shares Outstanding: 32.47M
TypeInstitutionsShares
Increased
112
3.02M
New
110
1.24M
Decreased
133
3.37M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-3.99%
Healthcare Providers & Services
-1.88%
Key Executives
Chairman/President/Chief Executive Officer/Director
Paul Kusserow
Chief Financial Officer
Scott Ginn
Chief Operating Officer
Christopher Gerard
Chief Human Resource Officer
Sharon Brunecz
Chief Information Officer
Michael North
Chief Compliance Officer
Denise Bohnert
Other
David Kemmerly
Lead Director/Independent Director
Richard Lechleiter
Independent Director
Vickie Capps
Independent Director
Molly Coye
Independent Director
Julie Klapstein
Independent Director
Teresa Kline
Independent Director
Bruce Perkins
Independent Director
Jeffrey Rideout
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AMED
Amedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. The Company owns and operates approximately 524 centers in 39 states and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness, such as heart disease, pulmonary disease, Alzheimer's and Human Immunodeficiency Virus (HIV)/Acquired Immuno Deficiency Syndrome (AIDS). The Personal care segment provides patients with assistance with the essential activities of daily living.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Amedisys Inc stock information, including NASDAQ:AMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMED stock methods without spending real money on the virtual paper trading platform.